Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TALZENNA DIN 02492040

Status: Approved
Holder: PFIZER CANADA ULC
Molecule: TALAZOPARIB (TALAZOPARIB TOSYLATE)

Health Canada record

Active ingredient(s)TALAZOPARIB (TALAZOPARIB TOSYLATE) 1 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01XK04 TALAZOPARIB
Original market date
Current status date06-Sep-2019
SourceHealth Canada DPD

Establishment licence of the holder

Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TALAZOPARIB (TALAZOPARIB TOSYLATE)

DINProductCompanyFormStrengthStatus
02492032TALZENNAPFIZER CANADA ULCCapsuleTALAZOPARIB (TALAZOPARIB TOSYLATE) 0.25 MGMarketed
02555050TALZENNAPFIZER CANADA ULCCapsuleTALAZOPARIB (TALAZOPARIB TOSYLATE) 0.1 MGMarketed
02555069TALZENNAPFIZER CANADA ULCCapsuleTALAZOPARIB (TALAZOPARIB TOSYLATE) 0.35 MGApproved
02555077TALZENNAPFIZER CANADA ULCCapsuleTALAZOPARIB (TALAZOPARIB TOSYLATE) 0.5 MGApproved

Notices of Compliance

NOCDateSubmissionReason
226152019-09-06New Drug Submission (NDS)
Request a quote for TALZENNA

How to read a Canadian DIN record